Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $984.95 | 39 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $447.31 | 22 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $332.04 | 13 | $0 (2024) |
| Zimmer Biomet Holdings, Inc. | $127.71 | 1 | $0 (2020) |
| Alexion Pharmaceuticals, Inc. | $62.25 | 2 | $0 (2023) |
| Medtronic Vascular, Inc. | $15.64 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $330.90 | 16 | PFIZER INC. ($242.92) |
| 2023 | $244.52 | 11 | Janssen Pharmaceuticals, Inc ($110.84) |
| 2022 | $70.60 | 2 | PFIZER INC. ($39.18) |
| 2021 | $39.54 | 2 | PFIZER INC. ($39.54) |
| 2020 | $145.41 | 2 | Zimmer Biomet Holdings, Inc. ($127.71) |
| 2018 | $60.35 | 3 | Janssen Pharmaceuticals, Inc ($44.71) |
| 2017 | $93.63 | 3 | Janssen Pharmaceuticals, Inc ($57.09) |
All Payment Transactions
39 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/01/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/01/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/23/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/21/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/12/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/12/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/24/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/14/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/30/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/03/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/19/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/06/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/09/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/23/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $26.46 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/12/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/13/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $28.88 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/01/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/30/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/06/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/08/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/11/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/28/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $27.16 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/15/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/18/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 259 | 714 | $211,080 | $54,808 |
| 2022 | 5 | 209 | 586 | $179,359 | $42,523 |
| 2021 | 4 | 264 | 638 | $215,910 | $52,781 |
| 2020 | 5 | 238 | 649 | $220,413 | $55,888 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 150 | 578 | $159,528 | $41,963 | 26.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 58 | 61 | $17,141 | $4,616 | 26.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 16 | 38 | $15,086 | $4,224 | 28.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 24 | 26 | $14,452 | $3,129 | 21.7% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 11 | 11 | $4,873 | $874.72 | 18.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 125 | 460 | $126,015 | $30,015 | 23.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 23 | 64 | $25,408 | $6,137 | 24.2% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 14 | 14 | $9,926 | $2,304 | 23.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 18 | 18 | $9,580 | $2,185 | 22.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 29 | 30 | $8,430 | $1,881 | 22.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 100 | 301 | $119,497 | $29,368 | 24.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 110 | 281 | $77,505 | $18,770 | 24.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 40 | 42 | $11,802 | $2,820 | 23.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 14 | 14 | $7,106 | $1,824 | 25.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 110 | 375 | $99,840 | $25,348 | 25.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 64 | 206 | $79,181 | $20,299 | 25.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 31 | 34 | $25,604 | $6,386 | 24.9% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2020 | 16 | 16 | $10,912 | $2,666 | 24.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 17 | 18 | $4,876 | $1,189 | 24.4% |
About Dr. Eric Wold, MD
Dr. Eric Wold, MD is a Internal Medicine healthcare provider based in Valhalla, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1386664944.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Wold, MD has received a total of $984.95 in payments from pharmaceutical and medical device companies, with $330.90 received in 2024. These payments were reported across 39 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($984.95).
As a Medicare-enrolled provider, Wold has provided services to 970 Medicare beneficiaries, totaling 2,587 services with total Medicare billing of $206,000. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Valhalla, NY
- Active Since 07/19/2006
- Last Updated 10/09/2015
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1386664944
Products in Payments
- ELIQUIS (Drug) $430.53
- XARELTO (Drug) $316.68
- Avenir (Device) $127.71
- SOLIRIS (Drug) $36.54
- ULTOMIRIS (Biological) $25.71
- VYNDAQEL (Drug) $16.78
- Reveal LINQ (Device) $15.64
- INVOKANA (Drug) $15.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Valhalla
Dr. Jay Doshi, M.d, M.D
Internal Medicine — Payments: $96,684
Luciano De Marco, M.d, M.D
Internal Medicine — Payments: $14,149
Neal Shah, M.d, M.D
Internal Medicine — Payments: $5,403
Sade Solola Nussbaum, Md, MD
Internal Medicine — Payments: $4,024
Rhonda Rubin, Md, MD
Internal Medicine — Payments: $2,982
Adrese Kandahari, M.d, M.D
Internal Medicine — Payments: $2,880